But abstinence is a significant bar similar to demanding that an antidepressant produce comprehensive remission of despair or that an analgesic totally get rid of ache. Recognizing this limitation, the FDA encourages builders of opioid2 and stimulant3 use problem prescription drugs to debate with FDA alternate approaches to evaluate adjustments in